The factory in Manesar will produce rapid tests for infectious diseases like dengue, malaria and HIV and export them across Asia Pacific, a region heavily impacted by these diseases, Khattar said as he inaugurated the facility in the presence of Namal Nawana, CEO and President of Alere firm.
The Manesar facility will initially produce more than 150 million rapid diagnostic tests per year and will have the capacity to expand to 300 million test.
The 180,000 square-feet factory in Manesar will initially employ approximately 300 people.
"Alere's new facility will support the goals of our 'Make in India' initiative, which seeks to transform India into a global manufacturing hub. Efforts to foster and expand India's medical device sector are important not only to our economic growth, but also to improve the health of the people of India," Nawana said.
"Alere believes in Prime Minister Narendra Modi's vision of 'Make in India' and is committed to improving access to affordable rapid diagnostics in India and throughout the Asia Pacific region through this new world-class manufacturing facility," Nawana said.